BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 15958538)

  • 1. Global gene expression profiling of circulating tumor cells.
    Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
    Smirnov DA; Foulk BW; Doyle GV; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2006 Mar; 66(6):2918-22. PubMed ID: 16540638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
    Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
    Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR.
    Sieuwerts AM; Kraan J; Bolt-de Vries J; van der Spoel P; Mostert B; Martens JW; Gratama JW; Sleijfer S; Foekens JA
    Breast Cancer Res Treat; 2009 Dec; 118(3):455-68. PubMed ID: 19115104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells in solid tumor in metastatic and localized stages.
    Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
    Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer.
    Wang JY; Yeh CS; Chen YF; Wu CH; Hsieh JS; Huang TJ; Huang SY; Lin SR
    Int J Mol Med; 2006 May; 17(5):737-47. PubMed ID: 16596255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular signature detection of circulating tumor cells using a panel of selected genes.
    Gervasoni A; Monasterio Muñoz RM; Wengler GS; Rizzi A; Zaniboni A; Parolini O
    Cancer Lett; 2008 May; 263(2):267-79. PubMed ID: 18262345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients.
    Hauch S; Zimmermann S; Lankiewicz S; Zieglschmid V; Böcher O; Albert WH
    Anticancer Res; 2007; 27(3A):1337-41. PubMed ID: 17593628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
    Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
    Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
    Shaffer DR; Leversha MA; Danila DC; Lin O; Gonzalez-Espinoza R; Gu B; Anand A; Smith K; Maslak P; Doyle GV; Terstappen LW; Lilja H; Heller G; Fleisher M; Scher HI
    Clin Cancer Res; 2007 Apr; 13(7):2023-9. PubMed ID: 17404082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.
    Nakagawa T; Martinez SR; Goto Y; Koyanagi K; Kitago M; Shingai T; Elashoff DA; Ye X; Singer FR; Giuliano AE; Hoon DS
    Clin Cancer Res; 2007 Jul; 13(14):4105-10. PubMed ID: 17634536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
    Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ
    Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.
    Pestrin M; Bessi S; Galardi F; Truglia M; Biggeri A; Biagioni C; Cappadona S; Biganzoli L; Giannini A; Di Leo A
    Breast Cancer Res Treat; 2009 Dec; 118(3):523-30. PubMed ID: 19597704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
    Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients.
    Gervasoni A; Sandri MT; Nascimbeni R; Zorzino L; Cassatella MC; Baglioni L; Panigara S; Gervasi M; Di Lorenzo D; Parolini O
    Oncol Rep; 2011 Jun; 25(6):1669-703. PubMed ID: 21455578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
    Hiraiwa K; Takeuchi H; Hasegawa H; Saikawa Y; Suda K; Ando T; Kumagai K; Irino T; Yoshikawa T; Matsuda S; Kitajima M; Kitagawa Y
    Ann Surg Oncol; 2008 Nov; 15(11):3092-100. PubMed ID: 18766405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
    Riethdorf S; Fritsche H; Müller V; Rau T; Schindlbeck C; Rack B; Janni W; Coith C; Beck K; Jänicke F; Jackson S; Gornet T; Cristofanilli M; Pantel K
    Clin Cancer Res; 2007 Feb; 13(3):920-8. PubMed ID: 17289886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.